Stauderman Kenneth A. 4
4 · CalciMedica, Inc. · Filed Jul 29, 2025
Insider Transaction Report
Form 4
Stauderman Kenneth A.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-07-25$3.65/sh−1,000$3,650→ 0 total(indirect: By Spouse) - Purchase
Common Stock
2025-07-28$3.96/sh+1,000$3,960→ 12,944 total
Footnotes (1)
- [F1]The sale of the common stock of CalciMedica, Inc. (the "Issuer") by the spouse of the reporting person reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person's spouse at a price of $1.85 per share on July 1, 2025. The reporting person has agreed to pay to the Issuer upon settlement of the sale, $1,799.83, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.